Kirsten Timms, Ph.D., VP Biomarker Discovery at Myriad Genetics Inc speaks about SABCS 2021 Abstract – P5-13-09 Identifying homologous recombination deficiency in breast cancer: Genomic instability score thresholds differ in breast cancer subtypes.
Kirsten Timms, PhD @myriadgenetics #SABCS21 #BreastCancer #Research Genomic Instability Score Thresholds
